IPO

Amanta Healthcare Launches INR 126 Cr IPO August 27, 2025 Amanta Healthcare has launched a ₹126 crore IPO through a fresh issue of 1 crore shares, with a price band of ₹120–₹126 per share. The listing is scheduled for September 4, 2025, on BSE and NSE.

Valuation of Manipal Hospitals Rises to $13 Bn After Sahyadri Deal; IPO Eyed for 2026 July 14, 2025 Manipal Hospitals’ valuation has jumped to around $13 Bn following its acquisition of Sahyadri Hospitals. The Temasek-backed hospital chain is expected to file draft papers for a $1 Bn IPO by June 2025, targeting a listing before March 2026.

Anthem Biosciences to Launch INR 3,395 Cr IPO on July 14 July 10, 2025 Anthem Biosciences will launch its INR 3,395 Cr IPO on July 14, through an offer-for-sale route. The Bengaluru-based CRDMO firm, with global clients across 44 countries, has set the price band at INR 540–INR 570. Anchor bidding opens July 11 ahead of its market debut.

Sudeep Pharma Files DRHP with SEBI for IPO June 26, 2025 Vadodara-based Sudeep Pharma has filed draft IPO papers with SEBI, proposing a INR 95 Cr fresh issue and an offer for sale of over 1 Cr shares. Funds will be used for capacity expansion and machinery procurement.

Biocon CEO Rules Out Immediate Biocon Biologics IPO June 25, 2025 Biocon CEO Siddharth Mittal said there are no immediate plans for a Syngene stake sale or Biocon Biologics IPO. The INR 4,500 Cr QIP will repay PE investors from the Viatris deal. Net debt stays at $1.1 Bn, but interest costs are set to drop 9-10% from next fiscal. Promoter stake falls to 54%, but majority control will be maintained.

Influx Healthtech Debuts Strong, Boosts India’s CDMO Play June 25, 2025 Mumbai-based Influx Healthtech made a robust stock market debut, marking a strong milestone for India’s healthtech contract manufacturing space. The company plans to scale its homecare and other divisions with fresh investments.

India’s Qure.AI Targets Profitability Next Year, IPO in Two Years May 21, 2025 Healthcare AI startup Qure.AI is eyeing a potential initial public offering (IPO) within two years, its CEO Prashant Warier confirmed.

Accretion Pharmaceuticals IPO to Open on May 14 May 13, 2025 The IPO of Gujarat-based Accretion Pharmaceuticals is set to open for subscription on Wednesday, May 14, 2025.

Gujarat Kidney & Super Speciality Eyes Growth with IPO; Targets Acquisitions, Robotics, & Expansion April 7, 2025 Gujarat Kidney & Super Speciality Hospital has filed its Draft Red Herring Prospectus (DRHP) with the Securities and Exchange Board of India (SEBI) to launch an initial public offering (IPO) comprising a fresh issue of up to 2.2 crore equity shares with a face value of INR 2 each.

Manipal Hospitals Finalizes Banks for $1 Bn IPO, Draft Filing by June March 25, 2025 Temasek-backed Manipal Hospitals has reportedly finalized a consortium of top banks to steer its highly anticipated $1 billion initial public offering. The healthcare chain has reportedly selected Goldman Sachs, Axis Capital, Jefferies, Kotak Mahindra Capital, and JP Morgan to manage the public offer.

Shanmuga Hospital IPO Opens for Subscription, Aims to Raise INR 20.62 Cr February 14, 2025 Shanmuga Hospital IPO opens for subscription from February 13-17, aiming to raise INR 20.62 Cr. Shares will be listed on the BSE SME platform on February 20.

Dr Agarwal's Healthcare IPO Opens for Subscription, Sees 6% Bids on Day 1 January 30, 2025 Dr Agarwal's Healthcare INR 3,027 Cr IPO opened for bidding, with 6% subscription on Day 1. The issue includes a INR 2,727 Cr offer for sale and will remain open until January 31.